ADP
39
3
FFIV
52
3
AAL
16
-13
GE
55
-5
LLY
67
-6
TAP
35
4
RF
61
3
LNC
40
-2
QRVO
59
6
PFE
45
-15
RHI
40
3
CTAS
27
3
NI
75
3
PNR
30
-2
LB
55
7
IBM
67
3
PCAR
56
11
AIZ
61
5
CA
15
6
AMT
39
3
ADP
39
3
FFIV
52
3
AAL
16
-13
GE
55
-5
LLY
67
-6
TAP
35
4
RF
61
3
LNC
40
-2
QRVO
59
6
PFE
45
-15
RHI
40
3
CTAS
27
3
NI
75
3
PNR
30
-2
LB
55
7
IBM
67
3
PCAR
56
11
AIZ
61
5
CA
15
6
AMT
39
3
Financhill
Back

Medipal Holdings Corp. 10K Form

Buy
72

MAHLY
Medipal Holdings Corp.

Last Price:
$19.10
Seasonality Move:
4.96%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive MAHLY News And Ratings

See the #1 stock for the next 7 days that we like better than MAHLY

MAHLY Financial Statistics

Sales & Book Value

Annual Sales: $24.1B
Cash Flow: $0
Price / Cash Flow: 0
Annual Sales: $19.98
Price / Book: 0.96

Profitability

EPS (TTM): 1.34290
Net Income (TTM): $348.4M
Gross Margin: $1.6B
Return on Equity: 6.87%
Return on Assets: 2.75%

Medipal Holdings Corp. Earnings Forecast

Key Medipal Holdings Corp. Financial Ratios

  • The Gross Profit Margin over the past 21 years for MAHLY is 6.60%.
  • The Selling, General & Administrative Expenses for MAHLY have been equal to 5.45% of Gross Profit Margin.
  • The Research & Development expenses have been 0.04% of Revenue.
  • The Interest Expense is 0.01% of Operating Income.
  • The Net Earning history of MAHLY is 1.40% of Total Revenues.
  • Per Share Earnings over the last 21 years have been positive in 12 years.

Medipal Holdings Corp. Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: OTCM
Industry: Health Care Providers & Services
Sector: Health Care
Current Symbol: MAHLY
Website: medipal.co.jp

Debt

Debt-to-Equity Ratio: 0.07
Current Ratio: 1.25
Quick Ratio: 0.98

Price-to-Earnings

Trailing P/E Ratio: 15.07
Forward P/E Ratio: 0

MAHLY Technical Analysis vs Fundamental Analysis

Buy
72
Medipal Holdings Corp. (MAHLY) is a Buy

Is Medipal Holdings Corp. a Buy or a Sell?